ENDOGEN ApS: Financial statements 2022
CVR: 29813337
Source: annual report 2022, Danish Business Authority
27/10/2021 – 26/10/2022
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -15,310 and a net result of DKK -15,405 compared with DKK -24,464 the year before. Equity in the 2022 report amounted to DKK 38,969. The solvency ratio was 45.5%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -15,310
- Profit/Loss
- DKK -15,405
- Equity
- DKK 38,969
- Total Assets
- DKK 85,635
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -15 t. | -15 t. | 39 t. | 1 |
| 2021 | - | -23 t. | -24 t. | 54 t. | 1 |
| 2020 | - | -18 t. | -18 t. | 79 t. | 1 |
| 2019 | - | -48 t. | -49 t. | 97 t. | 1 |
| 2018 | - | -26 t. | -26 t. | 83 t. | 1 |
Official annual report
Keep an eye on ENDOGEN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
ENDOGEN ApS has published its annual report for 2021. Gross profit came to DKK -23,164, and the net result was DKK -24,464.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.